Literature DB >> 15540905

In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method.

Kyung Ha Ryu1, Su Jin Cho, Yoon Jae Jung, Ju Young Seoh, Jeong Hae Kie, Sang Hyeok Koh, Hyoung Jin Kang, Hyo Seop Ahn, Hee Young Shin.   

Abstract

Dendritic cells (DCs) are the most potent antigen-presenting cells in terms of initiating primary T-cell-dependent immune responses. We devised a 2-step culture method for obtaining sufficient numbers of functional DCs from umbilical cord blood (CB) CD34+ cells. In the first step, CB CD34+ cells were expanded by stimulation with early-acting cytokines such as stem cell factor (SCF), flt3 ligand (FL), and thrombopoietin (TPO) to amplify the hematopoietic progenitor cells. In the second step, granulocyte-macrophage colony-stimulating factor and interleukin 4 were added, and incubation was continued for another 5 days to induce differentiation of the expanded cells into DCs. During the first step of culturing with TPO, SCF, and FL, the total numbers of nucleated cells gradually increased, peaking at 4 weeks (245.3-fold). During the second step, expression of CD1a, CD83, and CD86 increased. Electron microscopic findings showed that these cells had cytosolic expansion to form dendrites and major histocompatibility complex class II compartments, which are characteristic of DCs. Functional analyses revealed that these cells had phagocytic activity and were capable of stimulating allogeneic T-cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15540905     DOI: 10.1532/ijh97.a10406

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

Review 1.  Myeloid dendritic cells.

Authors:  R M Steinman; K Inaba
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

Review 2.  Functions of myeloid and lymphoid dendritic cells.

Authors:  A D McLellan; E Kämpgen
Journal:  Immunol Lett       Date:  2000-05-01       Impact factor: 3.685

Review 3.  Origin and differentiation of dendritic cells.

Authors:  C Ardavín; G Martínez del Hoyo; P Martín; F Anjuère; C F Arias; A R Marín; S Ruiz; V Parrillas; H Hernández
Journal:  Trends Immunol       Date:  2001-12       Impact factor: 16.687

4.  Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion.

Authors:  Svetlana N Bykovskaia; Galina V Shurin; Scott Graner; Mark L Bunker; Walter Olson; Ronald Thomas; Michael R Shurin; Stanley Marks; Walter J Storkus; Jeffrey Shogan
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

5.  Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood.

Authors:  E Liu; W Tu; H K Law; Y L Lau
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

6.  Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor.

Authors:  J F Arrighi; C Hauser; B Chapuis; R H Zubler; V Kindler
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

7.  In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium.

Authors:  G Ramadan; R E Schmidt; J Schubert
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

8.  Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.

Authors:  Z Zheng; M Takahashi; M Narita; K Toba; A Liu; T Furukawa; T Koike; Y Aizawa
Journal:  J Hematother Stem Cell Res       Date:  2000-08

9.  Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.

Authors:  K H Ryu; S Chun; S Carbonierre; S A Im; H L Kim; M H Shin; H Y Shin; H S Ahn; S Y Woo; J Y Seoh; J K Fraser
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  6 in total

1.  Production of functional dendritic cells from menstrual blood--a new dendritic cell source for immune therapy.

Authors:  Pham Van Phuc; Dang Hoang Lam; Vu Bich Ngoc; Duong Thi Thu; Nguyen Thi Minh Nguyet; Phan Kim Ngoc
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-03-18       Impact factor: 2.416

2.  Stem cell mediated tooth regeneration: new vistas in dentistry.

Authors:  M Sujesh; V Rangarajan; C Ravi Kumar; G Sunil Kumar
Journal:  J Indian Prosthodont Soc       Date:  2011-11-04

3.  Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

Authors:  Sandesh Subramanya; Sang-Soo Kim; Sojan Abraham; Jiahong Yao; Mukesh Kumar; Priti Kumar; Viraga Haridas; Sang-Kyung Lee; Leonard D Shultz; Dale Greiner; Manjunath N; Premlata Shankar
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

4.  Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy.

Authors:  Jeetendra Kumar; Rupali Gurav; Vaijayanti Kale; Lalita Limaye
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

5.  Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.

Authors:  Jeetendra Kumar; Vaijayanti Kale; Lalita Limaye
Journal:  Stem Cell Res Ther       Date:  2015-09-25       Impact factor: 6.832

6.  Stem cells: Boon to dentistry and medicine.

Authors:  P S Shilpa; Rachna Kaul; Nishat Sultana; Suraksha Bhat
Journal:  Dent Res J (Isfahan)       Date:  2013-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.